Innogenetics

Jury finds Abbott infringed Innogenetics HCV patent

Published in Genetics and Environmental Law Weekly, October 14th, 2006

In U.S. District Court for the Western District of Wisconsin, a jury unanimously found that Abbott Laboratories willfully infringed Innogenetics’ U.S. patent no. 5,846,704 (the '704 patent), which covers a method of genotyping the hepatitis C virus (HCV), Innogenetics reported.

The verdict directs Abbott to pay Innogenetics $7 million for infringement damages to date. That award may, at the judge's discretion, be increased up to 3 times that amount because the jury specifically determined Abbott's patent infringement was willful.

Further, based on the strength of the verdict and the determination that the infringement was willful, Innogenetics will...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly

Source: Genetics and Environmental Law Weekly (2006-10-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry